Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-16-003136)

Filing Details

Accession Number:: 0001562180-16-003136
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-09-09 10:25:35
Reporting Period:: 2016-09-07

Filing Date:: 2016-09-09
Accepted Time:: 2016-09-09 10:25:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1597553	Sage Therapeutics Inc.	SAGE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1304815	Kimi Iguchi	C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142	Cfo, Secretary And Treasurer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-09-07	2,500	$40.93	81,239	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
This transaction was executed in multiple trades at prices ranging from $40.51 USD to $41.05 USD; the price reported above reflects the weighted average sale price.